iBio
IBIO
#10074
Rank
S$34.96 M
Marketcap
S$1.56
Share price
-6.25%
Change (1 day)
-55.14%
Change (1 year)

iBio (IBIO) - Total assets

Total assets on the balance sheet as of June 2025 : S$30.04 Million

According to iBio's latest financial reports the company's total assets are S$30.04 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

iBio - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-06-30S$38.92 M-30.14%
2023-06-30S$55.71 M-59.68%
2022-06-30S$0.13 B-30.08%
2021-06-30S$0.19 B50.55%
2020-06-30S$0.13 B217.48%
2019-06-30S$41.34 M-29.58%
2018-06-30S$58.71 M18.45%
2017-06-30S$49.57 M-28.69%
2016-06-30S$69.51 M312.92%
2015-06-30S$16.83 M107.93%
2014-06-30S$8.09 M-31.8%
2013-06-30S$11.87 M-4.06%
2012-06-30S$12.37 M37.44%
2011-06-30S$9 M31.5%
2010-06-30S$6.84 M-3.87%
2009-06-30S$7.12 M47.44%
2008-06-30S$4.83 M-16.43%
2007-06-30S$5.78 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Genocea Biosciences
GNCA
S$50.26 M 67.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.89 B 6,201.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$249.87 B 831,541.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$0.39 B 1,199.75%๐Ÿ‡บ๐Ÿ‡ธ USA